Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Its strategy is to leverage an asset-rich in-licensing environment, with a focus on utilizing a team with a track record of execution in immunology, inflammation, fibrosis and oncology.